Study Exclusion reasons Rmk Reference
Rog, 2017 case report or case series

Rog 7th Joint ECTRIMS and ACTRIMS congress, Paris, France, 25-28 October 2017

Willis, 2016 case report or case series 'Thirteen pregnancies were recorded in twelve women (18%). Two pregnancies resulted inmiscarriage and one was terminated. The child of one patient who developed thyroid AID following treat- ment experienced transient neonatal hyperthyroidism.'

Willis Mult. Scler. 2016; 22:1215-23 10.1177/1352458515614092

Tuohy, 2015 not in pregnancy 'A total of 15 babies were born to 12 women treated with alemtuzumab during the course of the follow-up period after a median interval from most recent treatment of 26 months (range 13–86months). All deliveries and births were uncomplicated.'

Tuohy J. Neurol. Neurosurg. Psychiatry 2015; 86:208-15 10.1136/jnnp-2014-307721